Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CrkL anticorps

L’anticorps anti-CrkL Monoclonal Lapin est utilisé pour la détection de CrkL dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB, IHC, IF, ICC, IP et FACS.
N° du produit ABIN7882648
644,88 €
Plus frais de livraison 40,00 € et TVA
100 μL
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Recombinant CrkL anticorps (ABIN7882648)

Antigène

Voir toutes CrkL (CRKL) Anticorps
CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 101
  • 64
  • 18
  • 6
  • 2
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 114
  • 12
  • 1
Lapin

Clonalité

  • 101
  • 26
Monoclonal

Conjugué

  • 55
  • 8
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp CrkL est non-conjugé

Application

  • 85
  • 40
  • 36
  • 31
  • 26
  • 26
  • 17
  • 14
  • 12
  • 8
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunoprecipitation (IP), Flow Cytometry (FACS)

Clone

32C63
  • Fonction

    CrkL Antibody / Crk-like protein

    Purification

    Affinity chromatography

    Immunogène

    A synthesized peptide derived from human CrkL was used as the immunogen for the CRKL antibody.

    Isotype

    IgG
  • Indications d'application

    Optimal dilution of the CRKL antibody should be determined by the researcher.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store the CRKL antibody at -20oC.
  • Antigène

    CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))

    Autre désignation

    CrkL

    Sujet

    CrkL antibody detects Crk-like protein, encoded by the CRKL gene. Other identifiers include v-crk avian sarcoma virus CT10 oncogene homolog-like, adaptor protein CRKL, and CRK-like proto-oncogene. CrkL is a member of the Crk family of adaptor proteins that contain SH2 and SH3 domains. These modular domains mediate interactions with phosphorylated tyrosines and proline-rich motifs, enabling CrkL to assemble signaling complexes downstream of receptor tyrosine kinases, cytokine receptors, and integrins. By linking upstream receptors to downstream effectors, CrkL regulates processes such as cell adhesion, migration, proliferation, and survival.

    CrkL antibody is widely applied in cancer biology, immunology, and signal transduction research. CrkL is required for BCR-ABL signaling in chronic myeloid leukemia, where it mediates oncogenic transformation and survival. CrkL phosphorylation status serves as a biomarker for monitoring tyrosine kinase inhibitor therapy in leukemia patients. Beyond cancer, CrkL regulates immune receptor signaling, T cell activation, and integrin-mediated adhesion.

    Applications for CrkL antibody include western blotting, immunohistochemistry, immunofluorescence, and ELISA. Western blotting detects CrkL protein and phosphorylation isoforms, immunohistochemistry maps expression in tumors and lymphoid tissues, and immunofluorescence highlights localization at focal adhesions and signaling complexes. These methods provide comprehensive tools for analyzing CrkL biology in both normal and disease contexts.

    Dysregulation of CrkL contributes to leukemia, solid tumors, and immune disorders. Overexpression and abnormal phosphorylation promote cell transformation, invasion, and therapy resistance. By applying CrkL antibody, researchers can evaluate CrkL as a diagnostic marker and therapeutic target. In development, CrkL supports neural crest migration and organogenesis, linking it to congenital malformations when disrupted.

    CrkL interacts with proteins including CBL, paxillin, p130CAS, and STAT5, orchestrating diverse signaling cascades. Antibody-based detection allows detailed dissection of these interactions across pathways. NSJ Bioreagents provides CrkL antibody with validated specificity, supporting reliable detection in cancer, immunology, and signaling studies.

    UniProt

    P46109

    Pathways

    Interferon-gamma Pathway, Neurotrophin Signaling Pathway, Signaling of Hepatocyte Growth Factor Receptor
Vous êtes ici:
Chat with us!